查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1715734

數位 PCR 和即時PCR市場按產品類型、技術、樣本類型、應用和最終用戶分類——2025 年至 2030 年全球預測

Digital PCR & Real-Time PCR Market by Product Type, Technology, Sample Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2024年數位PCR和即時PCR市場價值將達到151億美元，2025年將達到164.2億美元，複合年成長率為9.01%，到2030年將達到253.5億美元。

執行摘要：數位PCR和即時PCR的應用前景

主要市場統計數據
基準年2024年 151億美元
預計2025年 164.2億美元
預測年份 2030 253.5億美元
複合年成長率（%） 9.01%

在快速發展的分子診斷和研究領域，數位 PCR 與傳統即時PCR技術的出現標誌著一個重要的轉折點。這份綜合報告探討了創新的數位 PCR 方法與廣泛實施的即時PCR技術之間的動態相互作用，後者長期以來一直是基因分析的基石。隨著對核酸分析的精度、靈敏度和定量要求的不斷提高，在嚴謹的研究、技術整合和創新應用的推動下，這些技術正在經歷變革性的轉變。

對於熱衷於利用先進遺傳工具進行臨床、環境和研究應用的相關人員來說，了解數位 PCR 和即時PCR現狀至關重要。隨著自動化、數據分析和小型化的發展趨勢，該領域不僅有望提高診斷能力，而且還將加速從研究到現實世界醫療和工業應用的進程。該報告透過細分分析、區域趨勢和關鍵產業參與者的研究提供了寶貴的見解，為 PCR 技術領域的策略性投資和未來創新奠定了基礎。

變革數位PCR與即時PCR市場

目前數位 PCR 和即時PCR的市場環境以技術不斷進步為推動力，不斷發生轉型轉變。在過去的十年中，重大進展帶來了靈敏度、精確度和吞吐量的提高，從而使研究人員和臨床醫生即使在具有挑戰性的樣本條件下也能獲得更可靠的結果。

從傳統擴增方法到精確數位量化平台的演進等技術突破重新定義了實驗室工作流程。先進的數據分析和自動化系統的整合，不僅提高了工作效率，也擴大了應用範圍。一個顯著的變化是從本體擴增技術轉向基於微流體的技術，該技術可以以無與倫比的精度對極低濃度的核酸進行量化。

此外，生物技術和自動化的融合為可擴展的高通量分析鋪平了道路。這種轉變在臨床診斷中尤其明顯，因為快速的周轉時間和準確性至關重要，並且在需要單細胞分析和複雜基因表現研究的研究場景中也是如此。儀器設計、試劑品質和軟體方面的平行創新為分子診斷工具性能設定了新的標準，開創了精度、速度與可操作洞察力相結合的時代。

研發投入增加、監管部門核准以及新興市場強勁需求等市場力量正在進一步推動這一轉變。這些因素的交織支持了永續的成長軌跡，並促進了數位 PCR 和即時PCR的持續創新。

市場分析的關鍵細分洞察

詳細的細分分析揭示了多方面的觀點，這對於理解 PCR 技術市場的細微差別至關重要。市場已根據產品類型進行了研究，並對儀器、試劑、消耗品、服務和軟體進行了全面評估。具體來說，試劑和耗材部門專注於酵素、主混合物以及探針和引物，以幫助相關人員確定準確的性能指標和成本促進因素。

除了產品類型之外，透過比較數位 PCR 和即時PCR，技術細分提供了雙重視角。數位PCR又可分為基於晶片的數位PCR和液滴數位PCR，各有各的優點和應用領域；即時PCR又可分為定量即時PCR和逆轉錄即時PCR。這種區別使得可以針對性地投資於滿足臨床診斷和研究環境精確需求的平台。

分析還涉及樣本類型，包括血液、環境、食物和組織頻譜。對於血液樣本，血漿和血清之間的細微評估可以深入了解樣本特定的挑戰和機會。環境樣本進一步分為土壤和水類型，強調需要多樣化的調查方法來適應樣本物理和化學性質的變化。

基於應用的細分透過詳細說明臨床、環境、食品安全、法醫學、調查等多種用途發揮至關重要的作用。在臨床應用中，傳染病檢查、腫瘤學檢測和移植診斷等專業凸顯了該技術徹底改變患者照護的潛力。這進一步補充了以過敏原和病原體測試為重點的食品安全應用的評估，以及深入基因表現、單細胞分析和幹細胞研究領域的研究應用。

最後，最終用戶細分揭示了該技術在學術和研究機構、臨床診斷實驗室、法醫學實驗室以及製藥和生物技術公司中的分佈。事實證明，這種細分對於了解不同行業之間的不同需求和使用模式至關重要，從而可以更好地進行產品開發和上市。總的來說，這些細分見解提供了了解當前市場動態以及新興 PCR 技術未來機會和挑戰所需的詳細資訊。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 感染疾病的傳播推動了對準確、及時的診斷解決方案的需求
      • 人們對個人化醫療和客製化治療的日益關注推動了 PCR 技術的應用。
      • 遺傳和基因組研究的擴展增加了對 PCR 等精確定量工具的需求。
    • 限制因素
      • 數位和即時PCR儀器的高成本及其校準和維護
    • 機會
      • 提高 PCR 分析技術靈敏度、效率和速度的技術進步
      • PCR在食品安全檢測和農業生物技術中的應用日益廣泛，擴大了市場機會
    • 任務
      • 技術複雜性以及缺乏數位和即時PCR技術的熟練專家
  • 市場區隔分析
    • 技術：利用數位PCR技術提高分子診斷準確性
    • 最終用戶：透過整合 PCR 技術在學術研究機構中推動科學發現
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. 數位PCR和即時PCR市場（按產品類型）

  • 裝置
  • 試劑和耗材
    • 酵素
    • 預混液
    • 探針和引子
  • 服務
  • 軟體

7. 數位PCR和即時PCR市場（按技術）

  • 數位PCR
    • 基於晶片的數位PCR
    • 液滴式數位PCR
  • 即時PCR
    • 定量即時PCR（qPCR）
    • 逆轉錄即時PCR（RT-qPCR）

8. 數位PCR和即時PCR市場（按樣本類型）

  • 血液樣本
    • 電漿
    • 血清
  • 環境樣品
    • 土壤樣本
    • 水樣
  • 食品樣品
  • 組織樣本

第9章數位PCR和即時PCR市場（按應用）

  • 臨床應用
    • 傳染病檢查
    • 腫瘤學檢測
    • 移植診斷
  • 環境應用
  • 食品安全
    • 過敏原檢測
    • 病原體檢測
  • 法醫學應用
  • 調查應用
    • 基因表現
    • 單細胞分析
    • 幹細胞研究

第 10 章 數位 PCR 和即時PCR市場（按最終用戶）

  • 學術研究所
  • 臨床診斷實驗室
  • 法醫學實驗室
  • 製藥和生物技術公司

11.美洲數位PCR和即時PCR市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12. 亞太地區數位PCR和即時PCR市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13. 歐洲、中東和非洲數位PCR和即時PCR市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Analytik Jena GmbH+Co. KG
  • Azure Biosystems Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biocompare
  • BIOMERIEUX SA
  • Bioneer Corporation
  • Danaher Corporation
  • ELITech Group by Bruker Corp
  • Enzo Life Sciences, Inc.
  • Eppendorf SE
  • Etcon Analytical and Environmental Systems & Services Ltd.
  • Explorea sro
  • F. Hoffmann-La Roche Ltd.
  • Hangzhou Longgene Scientific Instruments Co., Ltd.
  • Heal Force Bio-Meditech Holdings Limited
  • LABGENE Scientific SA
  • Merck KGaA
  • Promega Corporation
  • QIAGEN NV
  • Quidel Corporation
  • R-Biopharm AG
  • RainSure Scientific
  • SD Biosensor, Inc.
  • Solis BioDyne OU
  • STANDARD BIOTOOLS INC.
  • Takara Bio USA, Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corp.
Product Code: MRR-8760467AA4C1

The Digital PCR & Real-Time PCR Market was valued at USD 15.10 billion in 2024 and is projected to grow to USD 16.42 billion in 2025, with a CAGR of 9.01%, reaching USD 25.35 billion by 2030.

Executive Summary: Introduction to Digital PCR & Real-Time PCR Landscape

KEY MARKET STATISTICS
Base Year [2024] USD 15.10 billion
Estimated Year [2025] USD 16.42 billion
Forecast Year [2030] USD 25.35 billion
CAGR (%) 9.01%

In the rapidly evolving world of molecular diagnostics and research, the emergence of digital PCR alongside traditional real-time PCR technology marks a significant turning point. This comprehensive report explores the dynamic interplay between innovative digital PCR methodologies and the widely implemented real-time PCR techniques that have long been the cornerstone of genetic analysis. As the demand for greater precision, sensitivity, and quantification in nucleic acid analysis grows, these technologies have seen transformative shifts in adoption, driven by rigorous research, technological integrations, and innovative applications.

Understanding the landscape of digital and real-time PCR is essential for stakeholders keen on harnessing advanced genetic tools for clinical, environmental, and research applications. With growing trends in automation, data analysis, and miniaturization, the field not only promises enhanced diagnostic capabilities but also accelerates the path from research to real-world medical and industrial applications. This report provides valuable insights through segmentation analysis, regional trends, and an examination of key industry players, setting the stage for strategic investments and future innovations in the arena of PCR technology.

Transformative Shifts in the Digital PCR & Real-Time PCR Landscape

The current market environment for digital PCR and real-time PCR is characterized by transformative shifts fueled by continuous technological enhancements. Over the last decade, significant advancements have led to improved sensitivity, accuracy, and throughput, thereby enabling researchers and clinicians to obtain more reliable results even in challenging sample conditions.

Technological breakthroughs, such as the evolution from conventional amplification methods to precise digital quantification platforms, have redefined experimental workflows. The integration of advanced data analytics and automation systems has not only increased operational efficiency but has also expanded the range of applications. Notable changes include the migration from bulk amplification techniques to microfluidic-based technologies that allow for unparalleled precision in the quantification of nucleic acids at very low concentrations.

Furthermore, the convergence of biotechnology and automation has paved the way for scalable high-throughput assays. This shift has been particularly evident in clinical diagnostics where rapid turnaround times and accuracy are paramount, as well as in research scenarios requiring single-cell analysis and complex gene expression studies. The parallel improvements in instrument design, reagent quality, and software innovations have collectively set a new standard in the performance of molecular diagnostics tools, marking an era where precision and speed coalesce into actionable insights.

Market forces such as increased R&D investments, regulatory approvals, and robust demand in emerging economies are further fueling this transformation. The intersection of these factors supports a sustainable growth trajectory and encourages continuous innovation in both digital PCR and real-time PCR technologies.

Key Segmentation Insights for Market Analysis

An in-depth segmentation analysis reveals multifaceted perspectives that are vital for understanding the nuances of the PCR technology market. The market is studied based on product type, where a comprehensive evaluation differentiates between instruments, reagents and consumables, services, and software. Specifically, within the reagents and consumables segment, the focus on enzymes, master mixes, and probes and primers has helped stakeholders pinpoint precise performance indicators and cost drivers.

In addition to the product type, the technology segmentation provides a dual outlook by comparing digital PCR and real-time PCR. Digital PCR is partitioned further into chip-based digital PCR and droplet digital PCR, each with its unique strengths and application areas, while real-time PCR is further categorized into quantitative real-time PCR and reverse transcription real-time PCR. Such distinctions allow for targeted investments in platforms that meet the precise needs of clinical diagnostics and research environments.

The analysis also extends to sample type, covering a spectrum that includes blood, environmental, food, and tissue samples. Within blood samples, nuanced evaluations between plasma and serum have offered insights into sample-specific challenges and opportunities. Environmental samples are further dissected into soil and water types, emphasizing the need for diverse methodological adaptations to suit varying physical and chemical properties of the samples.

Application-based segmentation plays a critical role by detailing diverse uses such as clinical, environmental, food safety, forensic, and research applications. Within clinical applications, specialties like infectious disease testing, oncology testing, and transplant diagnostics highlight the technology's potential to revolutionize patient care. This is further complemented by the evaluation of food safety applications focusing on allergen and pathogen testing, as well as research applications that delve into areas of gene expression, single cell analysis, and stem cell research.

Finally, the end-user segmentation sheds light on the distribution of technology across academic and research institutes, clinical diagnostics laboratories, forensic labs, and pharmaceutical and biotechnology companies. This segmentation has proven integral to understanding the differing demands and usage patterns across various sectors, enabling a more tailored approach to product development and market deployment. Overall, these segmentation insights provide the granular detail needed to understand not only the current market dynamics but also the future potential and challenges of emerging PCR technologies.

Based on Product Type, market is studied across Instruments, Reagents & Consumables, Services, and Software. The Reagents & Consumables is further studied across Enzymes, Master Mixes, and Probes & Primers.

Based on Technology, market is studied across Digital PCR and Real-Time PCR. The Digital PCR is further studied across Chip-Based Digital PCR and Droplet Digital PCR. The Real-Time PCR is further studied across Quantitative Real-Time PCR (qPCR) and Reverse Transcription Real-Time PCR (RT-qPCR).

Based on Sample Type, market is studied across Blood Samples, Environmental Samples, Food Samples, and Tissue Samples. The Blood Samples is further studied across Plasma and Serum. The Environmental Samples is further studied across Soil Samples and Water Samples.

Based on Application, market is studied across Clinical Applications, Environmental Applications, Food Safety, Forensic Application, and Research Applications. The Clinical Applications is further studied across Infectious Disease Testing, Oncology Testing, and Transplant Diagnostics. The Food Safety is further studied across Allergen Testing and Pathogen Testing. The Research Applications is further studied across Gene Expression, Single Cell Analysis, and Stem Cell Research.

Based on End-User, market is studied across Academic & Research Institutes, Clinical Diagnostics Laboratories, Forensic Labs, and Pharmaceutical & Biotechnology Companies.

Regional Trends Shaping the Digital PCR & Real-Time PCR Market

The regional dynamics of the market reveal distinct trends that vary significantly across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions. In the Americas, there is a steady increase in regulatory acceptance and reimbursement policies that bolster the adoption of advanced PCR technologies in clinical settings. This region marks substantial advancements in both research and diagnostic services, driven by robust investments in healthcare infrastructure and a strong network of academic institutions.

Across Europe, the Middle East, and Africa, collaborative efforts among institutions, universities, and government agencies have accelerated the integration of digital and real-time PCR technologies. Here, emphasis is placed not only on research but also on public health applications, particularly the drive towards better disease screening and environmental monitoring. Markets in these regions have seen a rapid evolution due to increased funding for R&D and a willingness to adopt innovative diagnostic technologies.

In the Asia-Pacific, accelerated economic growth and rapid modernization of healthcare services have positioned the region as a hub for technological adoption and innovation. The integration of PCR techniques in both large-scale industrial settings and smaller, agile research facilities has resulted in a diverse market landscape. This area is particularly noted for its strong focus on cost efficiency and the adaptation of technologies that can cater to varying economic contexts. Overall, the interplay of regional policies, economic drivers, and technological readiness across these regions creates a fertile environment for sustained growth in the PCR market.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Companies Steering Innovation and Competition

A closer look at the competitive landscape highlights several key companies that have left an indelible mark on the evolution and direction of PCR technology. Companies such as Abbott Laboratories, Inc. and Agilent Technologies, Inc. have been instrumental in driving innovation in both digital and real-time PCR platforms, balancing the demands for high-throughput instrumentation with cost-effective solutions. Analytik Jena GmbH+Co. KG and Azure Biosystems Inc. also feature prominently, underscoring a commitment to refining technology that enhances both accuracy and usability.

Continuing this trend, Becton, Dickinson and Company and Bio-Rad Laboratories, Inc. have consistently demonstrated leadership through technological integrations that streamline workflows in clinical laboratories. The extensive contributions from BIOMERIEUX S.A. and Bioneer Corporation further accentuate the competitive drive present in this dynamic market. Not far behind, Danaher Corporation and ELITech Group by Bruker Corp provide state-of-the-art solutions that facilitate faster diagnostics and research analysis.

Other notable players including Enzo Life Sciences, Inc., Eppendorf SE, and Etcon Analytical and Environmental Systems & Services Ltd. deliver reliable and innovative products tailored to meet the rigorous needs of both academic research and industrial applications. Explorea s.r.o, F. Hoffmann-La Roche Ltd., and Hangzhou Longgene Scientific Instruments Co., Ltd. are continually pushing the boundaries of technology with a focus on precision and efficiency.

The landscape is further enriched by contributions from Heal Force Bio-Meditech Holdings Limited, LABGENE Scientific SA, and Merck KGaA, who are known for their robust product pipelines and expansive geographic footprints. Leaders from Promega Corporation and QIAGEN N.V. have streamlined the integration of digital platforms with traditional PCR, while Quidel Corporation, R-Biopharm AG, and RainSure Scientific have consistently met the evolving demands of diagnostic testing. Additional significant innovators such as SD Biosensor, Inc., Solis BioDyne OU, and STANDARD BIOTOOLS INC. have set high standards in quality and performance. The contributions of Takara Bio USA, Inc., Thermo Fisher Scientific Inc., and Zymo Research Corp. further underscore the innovative spirit and competitive drive that continue to shape the industry. Their combined efforts not only reflect the current state of the market but also pave the way for new advancements in PCR-based methodologies.

The report delves into recent significant developments in the Digital PCR & Real-Time PCR Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Inc., Agilent Technologies, Inc., Analytik Jena GmbH+Co. KG, Azure Biosystems Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biocompare, BIOMERIEUX S.A., Bioneer Corporation, Danaher Corporation, ELITech Group by Bruker Corp, Enzo Life Sciences, Inc., Eppendorf SE, Etcon Analytical and Environmental Systems & Services Ltd., Explorea s.r.o, F. Hoffmann-La Roche Ltd., Hangzhou Longgene Scientific Instruments Co., Ltd., Heal Force Bio-Meditech Holdings Limited, LABGENE Scientific SA, Merck KGaA, Promega Corporation, QIAGEN N.V., Quidel Corporation, R-Biopharm AG, RainSure Scientific, SD Biosensor, Inc., Solis BioDyne OU, STANDARD BIOTOOLS INC., Takara Bio USA, Inc., Thermo Fisher Scientific Inc., and Zymo Research Corp.. Actionable Recommendations for Industry Leaders

Industry leaders aiming to leverage the full potential of PCR technologies must focus on several strategic areas. Investing in research and development to foster greater integration of digital platforms with conventional methodologies is paramount. The convergence of emerging software solutions with state-of-the-art instrumentation should be a priority, as it allows for seamless data integration, improved workflow automation, and enhanced result accuracy.

Leaders should also consider diversifying their product portfolios to encompass the varied aspects of segmentation such as product types, technology formats, sample types, and application-specific needs. Embracing a tailored approach towards the reagents and consumables segment-particularly refining focus on enzymes, master mixes, and probes and primers-can yield significant competitive advantages. By aligning efforts to cater to both chip-based and droplet digital PCR, as well as quantitative and reverse transcription real-time PCR, companies can ensure their offerings meet the diverse demands of clinical diagnostics and cutting-edge research.

It is equally important for industry stakeholders to invest in training and support services to foster effective adoption of new platforms. This includes enhancing customer education on technological capabilities and integrating feedback mechanisms to rapidly adapt to emerging requirements. Additionally, expanding market reach by targeting distinct end-user segments, including academic and research institutes, clinical diagnostic laboratories, forensic labs, and pharmaceutical and biotechnology companies, will facilitate broader acceptance and usage of advanced PCR technologies.

Staying ahead in a competitive market also requires continuous monitoring of regulatory and reimbursement conditions across different regions. Keeping abreast of evolving guidelines can help companies not only comply with standards but also take advantage of emerging opportunities in markets that prioritize rapid diagnostics and patient care. Finally, forging strategic partnerships with research institutions and key opinion leaders will help accelerate technological adoption and advance market presence. These actionable recommendations, crafted to foster innovation, operational excellence, and enhanced customer engagement, provide a roadmap for industry leaders seeking to unlock the full potential of modern PCR technology.

Conclusion: Embracing the Future of PCR Technology

In summary, the landscape of PCR technology, encompassing both digital and real-time formats, is characterized by continuous innovation and transformative market shifts. The convergence of cutting-edge instrumentation, refined reagent solutions, and robust software has set unprecedented standards in diagnostic accuracy and research capabilities. The detailed segmentation analysis underscores the tactical importance of addressing diverse facets of the market-from product type and technology to sample type, application areas, and end-user requirements. This comprehensive approach not only reflects the current trends but also captures the future potential inherent in the evolution of PCR methodologies.

The regional insights further underscore the role of geographically driven dynamics where regions like the Americas, Europe, Middle East & Africa, and Asia-Pacific contribute uniquely to market growth through tailored regulatory frameworks and investment in healthcare infrastructure. Meanwhile, the competitive landscape, spearheaded by industry leaders such as Abbott Laboratories, Inc., Agilent Technologies, Inc., and numerous other innovators, exemplifies the relentless pursuit of excellence and adaptation.

Embracing these insights and traversing the challenges of the modern diagnostic arena calls for a balanced mix of technological foresight and strategic agility. The future of PCR technology is not only about the evolution of the instruments and reagents but also about a shift in paradigms that integrates deep analytics, enhanced automation, and a commitment to precise diagnostic outcomes. Stakeholders who adapt quickly to these shifting market dynamics will be better positioned to lead in this arena.

Ultimately, the confluence of innovation, strategic segmentation, and regional adaptability creates an environment ripe for continuous growth and improved patient care. Leaders equipped with actionable insights and a forward-looking approach can harness these opportunities to pioneer advancements that redefine the landscape of molecular diagnostics and research.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of infectious diseases fueling the need for precise and timely diagnostic solutions
      • 5.1.1.2. Growing focus on personalized medicine and tailored therapies boosting the use of PCR technologies
      • 5.1.1.3. Expansion of genetic and genomic research promoting the need for accurate quantification tools like PCR
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of digital and real-time PCR equipment along with their calibration and maintenance
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements enhancing the sensitivity, efficiency, and speed of PCR analysis techniques
      • 5.1.3.2. Increased application of PCR in food safety testing and agriculture biotechnology expanding market opportunities
    • 5.1.4. Challenges
      • 5.1.4.1. Technological complexities and shortage of skilled professionals in digital and real-time PCR technologies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Advancing precision in molecular diagnostics with digital PCR technology
    • 5.2.2. End-User: Advancing scientific discovery through the integration of pcr technologies in academic and research institutes
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital PCR & Real-Time PCR Market, by Product Type

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables
    • 6.3.1. Enzymes
    • 6.3.2. Master Mixes
    • 6.3.3. Probes & Primers
  • 6.4. Services
  • 6.5. Software

7. Digital PCR & Real-Time PCR Market, by Technology

  • 7.1. Introduction
  • 7.2. Digital PCR
    • 7.2.1. Chip-Based Digital PCR
    • 7.2.2. Droplet Digital PCR
  • 7.3. Real-Time PCR
    • 7.3.1. Quantitative Real-Time PCR (qPCR)
    • 7.3.2. Reverse Transcription Real-Time PCR (RT-qPCR)

8. Digital PCR & Real-Time PCR Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood Samples
    • 8.2.1. Plasma
    • 8.2.2. Serum
  • 8.3. Environmental Samples
    • 8.3.1. Soil Samples
    • 8.3.2. Water Samples
  • 8.4. Food Samples
  • 8.5. Tissue Samples

9. Digital PCR & Real-Time PCR Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Applications
    • 9.2.1. Infectious Disease Testing
    • 9.2.2. Oncology Testing
    • 9.2.3. Transplant Diagnostics
  • 9.3. Environmental Applications
  • 9.4. Food Safety
    • 9.4.1. Allergen Testing
    • 9.4.2. Pathogen Testing
  • 9.5. Forensic Application
  • 9.6. Research Applications
    • 9.6.1. Gene Expression
    • 9.6.2. Single Cell Analysis
    • 9.6.3. Stem Cell Research

10. Digital PCR & Real-Time PCR Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Clinical Diagnostics Laboratories
  • 10.4. Forensic Labs
  • 10.5. Pharmaceutical & Biotechnology Companies

11. Americas Digital PCR & Real-Time PCR Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Digital PCR & Real-Time PCR Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Digital PCR & Real-Time PCR Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. QIAGEN launches QIAcuityDx digital PCR system to transform clinical oncology with precision medicine
    • 14.3.2. Transasia-Erba pioneers high-accuracy MonkeyPox RT-PCR kit with robust global production capability
    • 14.3.3. GCCL's pioneering introduction of ddPCR technology in South Korea transforms clinical trial sample analysis
    • 14.3.4. Bio-Rad's advanced multiplexed digital PCR assay revolutionizes breast cancer mutation detection
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Analytik Jena GmbH+Co. KG
  • 4. Azure Biosystems Inc.
  • 5. Becton, Dickinson and Company
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Biocompare
  • 8. BIOMERIEUX S.A.
  • 9. Bioneer Corporation
  • 10. Danaher Corporation
  • 11. ELITech Group by Bruker Corp
  • 12. Enzo Life Sciences, Inc.
  • 13. Eppendorf SE
  • 14. Etcon Analytical and Environmental Systems & Services Ltd.
  • 15. Explorea s.r.o
  • 16. F. Hoffmann-La Roche Ltd.
  • 17. Hangzhou Longgene Scientific Instruments Co., Ltd.
  • 18. Heal Force Bio-Meditech Holdings Limited
  • 19. LABGENE Scientific SA
  • 20. Merck KGaA
  • 21. Promega Corporation
  • 22. QIAGEN N.V.
  • 23. Quidel Corporation
  • 24. R-Biopharm AG
  • 25. RainSure Scientific
  • 26. SD Biosensor, Inc.
  • 27. Solis BioDyne OU
  • 28. STANDARD BIOTOOLS INC.
  • 29. Takara Bio USA, Inc.
  • 30. Thermo Fisher Scientific Inc.
  • 31. Zymo Research Corp.

LIST OF FIGURES

  • FIGURE 1. DIGITAL PCR & REAL-TIME PCR MARKET MULTI-CURRENCY
  • FIGURE 2. DIGITAL PCR & REAL-TIME PCR MARKET MULTI-LANGUAGE
  • FIGURE 3. DIGITAL PCR & REAL-TIME PCR MARKET RESEARCH PROCESS
  • FIGURE 4. DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. DIGITAL PCR & REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. DIGITAL PCR & REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. DIGITAL PCR & REAL-TIME PCR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL PCR & REAL-TIME PCR MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOIL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY WATER SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 164. AUSTRALIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 170. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 172. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 176. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 177. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 180. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 182. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 185. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 186. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 188. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 189. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 190. INDIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 193. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 195. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 196. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 198. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 199. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 201. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 202. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 203. INDONESIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 206. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 208. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 209. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 211. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 212. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 214. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 215. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 216. JAPAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 219. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 221. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 222. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 224. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 225. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 227. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 228. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 229. MALAYSIA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 232. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 234. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 237. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 238. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 240. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 241. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 242. PHILIPPINES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 245. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 246. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 247. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 248. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 250. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 251. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 253. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 254. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 255. SINGAPORE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 256. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 258. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 260. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 261. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 263. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 264. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 266. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 268. SOUTH KOREA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 271. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 273. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 274. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 276. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 277. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 279. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 280. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 281. TAIWAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 282. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 284. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 285. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 286. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 287. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 289. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 290. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 292. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 293. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 294. THAILAND DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 297. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 298. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 299. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2030 (USD MILLION)
  • TABLE 300. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY BLOOD SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 302. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL SAMPLES, 2018-2030 (USD MILLION)
  • TABLE 303. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 305. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 306. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 307. VIETNAM DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2030 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-T